GLP-1 Authority Hub
GLP-1 treatment guides, drug comparisons, dosing, safety, and access.
Start with the basics, then move into semaglutide, tirzepatide, retatrutide, side effects, cost, diet, and the full GLP-1 drug class.

Start here
New to GLP-1 therapy?
These articles explain what GLP-1 does, what incretins are, how receptor agonists work, and which products sit inside the drug class.
What Does GLP-1 Do? A Plain-English Explanation
A plain-English guide to what the GLP-1 hormone does: glucose-dependent insulin release, glucagon suppression, slowed gastric emptying, and appetite control.
What Are Incretins? GLP-1, GIP & the Hormone System Behind Modern Weight Loss Drugs
Incretins are gut hormones, chiefly GLP-1 and GIP, that trigger most of your post-meal insulin release. Here is how the incretin system works and how it powers modern weight-loss drugs.
GLP-1 Receptor Agonist: What the Term Means & Why It Matters for Treatment
A more technical definition of "GLP-1 receptor agonist": what the GLP-1 receptor is, how receptor binding and activation work, and why the precise wording separates these drugs from DPP-4 inhibitors.
GLP-1 Products: Every Approved Option Available in 2026 (Full Reference Guide)
A full 2026 roster of FDA-approved GLP-1 and incretin products, with brand, molecule, maker, indication and delivery form for each option on the market.
Topic hubs
Choose the GLP-1 question you are trying to answer.

Semaglutide
Semaglutide uses, Ozempic, Wegovy, Rybelsus, dosage context, side effects, safety warnings, and GLP-1 comparisons.
Open hub
Tirzepatide
Tirzepatide uses, Mounjaro, Zepbound, dosage context, side effects, warnings, cost, access, and GLP-1 comparisons.
Open hub
Retatrutide
Retatrutide mechanism, clinical trial data, benefits, dosage context, side effects, availability, cost, and comparisons.
Open hub
Side Effects
GLP-1 side effects, nausea, vomiting, diarrhea, constipation, fatigue, reflux, red flags, long-term risks, and management tips.
Open hub
Cost and Access
Coupons, savings programs, prescriptions, telehealth, OTC claims, compounding, and drug-specific cost guides.
Open hub
Diet and Body Composition
Diet, fat loss, muscle retention, protein, plateaus, PCOS, women-specific context, and long-term weight management.
Open hub
Drug List
Approved GLP-1 products, receptor agonists, analogues, diabetes drugs, new drugs, and manufacturer guides.
Open hubQuick map
How the core GLP-1 topics connect.
Semaglutide
Single-receptor GLP-1 benchmark for Ozempic, Wegovy, and related comparison pages.
Tirzepatide
Dual GLP-1/GIP agonist context for Mounjaro, Zepbound, dosing, cost, and side effects.
Retatrutide
Pipeline triple agonist coverage for trial data, dosage, benefits, cost, and safety questions.
Latest
Latest GLP-1 articles

WVE-007 (James Bond Peptide): What It Is and Why the Nickname Is Wrong
It is not a peptide, and the Bond reference comes from a gene rather than a film. What is genuinely interesting about it is the muscle question.

Petrelintide & Eloralintide: What These Amylin Analogues Are and Where They Stand
Two once weekly amylin drugs aiming for GLP-1 style weight loss with far less nausea. Both are in trials, neither is available, and the tolerability claim is the point.

NA-931 (Bioglutide): What It Is and How Much of the Claim Is Verified
An oral four-receptor agonist would be a genuine advance if it works. Here is what is actually established about it, and what rests on company statements alone.

Brenipatide: What It Is, Why It Is Monthly, and What Is Not Yet Known
A once-monthly GLP-1 and GIP agonist aimed at addiction and psychiatric conditions rather than obesity. The strategy is interesting. The efficacy data does not exist yet.

Aleniglipron (GSBR-1290): What It Is and Where the Trials Stand
Aleniglipron is an oral GLP-1 receptor agonist that is not a peptide at all. What that difference means, what phase 2 showed, and what phase 3 is testing.

Albiglutide (Tanzeum): What It Was and Why It Disappeared
The once-weekly GLP-1 that worked, sold for three years, and was withdrawn for commercial reasons. What it did, why it lost, and what a patient would take instead.

Adipotide (FTPP): The Fat-Targeting Peptide and Why It Never Reached People
Adipotide destroys the blood supply feeding white fat. The primate results were striking, the kidney toxicity was not, and no human trial has ever been completed.

Tesofensine Dosage Guide: Trial Ranges, Timing and Where the Ceiling Is
The doses studied in the phase 2 obesity work, why 1 mg was not taken forward, and the cardiovascular reason timing and dose matter more here than usual.

Pramlintide (Symlin): Dosage, What It Does, and Where It Fits Now
The only approved amylin analogue, dosed before every meal. Exact dosing for type 1 and type 2, what the weight loss trials actually showed, and the boxed warning.

Amycretin Peptide: What It Is and What the Trial Data Shows So Far
Novo Nordisk's single-molecule GLP-1 and amylin agonist, in injected and oral forms. The early weight loss numbers, what they do and do not prove, and what comes next.

Tirzepatide Beyond Weight Loss: What Else It Appears to Do
Food noise, lipids, alcohol craving, joint pain, mood and menopause. What tirzepatide appears to do beyond the scale, sorted by how good the evidence actually is.

Mounjaro Injection: How to Do It, Where, and What to Avoid
A practical walkthrough of the Mounjaro pen: the three approved sites, the two clicks that matter, missed dose rules, storage limits and the common mistakes.
Full library
